A flexural exanthem following postexposure prophylaxis
- PMID: 35297086
- PMCID: PMC9313790
- DOI: 10.1111/ced.15131
A flexural exanthem following postexposure prophylaxis
Erratum in
-
Corrigendum.Clin Exp Dermatol. 2022 Dec;47(12):2350. doi: 10.1111/ced.15401. Clin Exp Dermatol. 2022. PMID: 36440612 Free PMC article. No abstract available.
Abstract
We report a case of symmetrical drug-related intertriginous and flexural exanthema following antiretroviral postexposure prophylactic medications, tenofovir and emtricitabine, commencement of which preceded the onset of the rash. Tenofovir and emtricitabine are both nucleoside reverse transcriptase inhibitor medications, commonly used to prevent development of AIDS.
© 2022 The Authors. Clinical and Experimental Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.
Figures
References
-
- Häusermann P, Harr T, Bircher AJ. Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome? Contact Dermatitis 2004; 51: 297–310. - PubMed
-
- Winnicki M, Shear NH. A systematic approach to systemic contact dermatitis and symmetric drug‐related intertriginous and flexural exanthema (SDRIFE): a closer look at these conditions and an approach to intertriginous eruptions. Am J Clin Dermatol 2011; 12: 171–80. - PubMed
-
- Nespoulous L, Matei I, Charissoux A et al. Symmetrical drug‐related intertriginous and flexural exanthema (SDRIFE) associated with pristinamycin, secnidazole, and nefopam, with a review of the literature. Contact Dermatitis 2018; 79: 378–80. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources